Provided by Tiger Fintech (Singapore) Pte. Ltd.

Biodesix, Inc.

0.3029
+0.02117.49%
Post-market: 0.3000-0.0029-0.96%19:52 EDT
Volume:2.45M
Turnover:731.83K
Market Cap:44.39M
PE:-1.06
High:0.3100
Open:0.2813
Low:0.2750
Close:0.2818
Loading ...

Biodesix Approves Reverse Stock Split at Annual Meeting

TIPRANKS
·
22 May

Biodesix Is Maintained at Sector Outperform by Scotiabank

Dow Jones
·
21 May

Biodesix price target lowered to $2 from $3 at Scotiabank

TIPRANKS
·
21 May

Biodesix Inc. to Participate in 22nd Annual Craig-Hallum Institutional Investor Conference

Reuters
·
21 May

Director and 10% Owner Jack W. Schuler Reports Acquisition of Common Shares of Biodesix Inc

Reuters
·
21 May

Biodesix Analysts Lower Their Forecasts After Downbeat Q1 Results

Benzinga
·
15 May

Biodesix Is Maintained at Buy by Lake Street

Dow Jones
·
15 May

Biodesix Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
14 May

Lake Street Sticks to Its Buy Rating for Biodesix (BDSX)

TIPRANKS
·
14 May

Biodesix price target lowered to $2 from $3 at Lake Street

TIPRANKS
·
14 May

Biodesix Cut to Market Perform From Outperform by William Blair

Dow Jones
·
14 May

William Blair Downgrades Biodesix to Market Perform From Outperform

MT Newswires Live
·
14 May

U.S. RESEARCH ROUNDUP-Fair Issac, First Solar, UnitedHealth

Reuters
·
14 May

Biodesix Inc. Chief Commercial Officer Kieran O'Kane Reports Disposal of Common Shares

Reuters
·
14 May

Biodesix Inc. President & CEO Scott Hutton Reports Disposal of Common Shares

Reuters
·
14 May

Biodesix Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Biodesix Q1 GAAP EPS $(0.08) Misses $(0.07) Estimate, Sales $17.96M Miss $19.47M Estimate

Benzinga
·
14 May

BRIEF-Biodesix Q1 Operating Expenses USD 900 Thousand

Reuters
·
14 May

Biodesix Inc. Reports 21% Increase in Q1 2025 Revenue, 18% Improvement in Net Loss

Reuters
·
14 May

Biodesix Inc - Updates 2025 Revenue Guidance to $80-85 Mln

THOMSON REUTERS
·
14 May